Central PharmaceuticalNo3 Share Price

Equities

DP3

VN000000DP36

Pharmaceuticals

End-of-day quote HANOI S.E. 23:00:00 11/06/2024 BST 5-day change 1st Jan Change
64,400 VND +0.47% Intraday chart for Central PharmaceuticalNo3 +3.87% -1.68%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Dynamic Chart
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
Central Pharmaceutical Joint Stock Company No. 3 Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Central Pharmaceutical Joint Stock Company No. 3 Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
More news
1 day+0.47%
1 week+3.87%
Current month+4.55%
1 month+4.89%
3 months-12.97%
6 months-0.92%
Current year-1.68%
More quotes
1 week
63 500.00
Extreme 63500
65 900.00
1 month
60 700.00
Extreme 60700
65 900.00
Current year
59 900.00
Extreme 59900
77 000.00
1 year
44 240.00
Extreme 44240
80 800.00
3 years
34 800.00
Extreme 34800
80 800.00
5 years
24 360.00
Extreme 24360
80 800.00
10 years
5 800.00
Extreme 5800
80 800.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 28/02/17
Chairman 63 31/12/83
Comptroller/Controller/Auditor - 17/07/19
Members of the board TitleAgeSince
Chairman 63 31/12/83
Director/Board Member 60 23/04/14
Director/Board Member 44 23/05/19
More insiders
Central Pharmaceutical Joint Stock Company No3 (FORIPHARM) is a Vietnam-based company operating in the pharmaceutical industry, which is mainly engaged in the manufacture and trading of pharmaceutical products. The Company's leading products include botanical medicine and other types of drugs, health supplements and cosmetics, among others. Besides, the Company partakes in the commerce of medical equipment and supplies, as well as the conduct of medical research.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW